Business Insider

Lexicon Pharmaceuticals Secures Up To $200 Million Non-Dilutive Term Loan Financing

THE WOODLANDS, Texas, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX) today announced that it has entered into a definitive term loan agreement with BioPharma Credit PLC ...
Benzinga.com

Lexicon Pharmaceuticals And 2 Other Stocks Under $5 Insiders Are Aggressively Buying

The Dow Jones closed lower by over 200 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders ...
Reuters

Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal

March 28 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is licensing Lexicon Pharmaceuticals' (LXRX.O), opens new tab experimental obesity drug in a deal worth up to $1 billion, the Danish ...
Nasdaq

Lexicon Announces Completion of Enrollment in Phase 2B PROGRESS Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)

THE WOODLANDS, Texas, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the completion of patient enrollment in the PROGRESS (A Phase 2b, Dose-ranging, ...
Reuters

Lexicon Pharmaceuticals Secures Up To $200 Million Non-Dilutive Term Loan Financing

* LEXICON PHARMACEUTICALS INC- THE ‍FIRST $150 MILLION IS AVAILABLE IMMEDIATELY AND AN ADDITIONAL TRANCHE OF $50 MILLION IS AVAILABLE FOR DRAW BY MARCH 2019 * LEXICON PHARMACEUTICALS-SECURES UP TO ...